Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF

被引:99
|
作者
Mansi, JA
Rivest, S
Drolet, G
机构
[1] UNIV LAVAL, CHUL, UNITE RECH HYPERTENS, LAB NEUROBIOL & HYPERTENS, Ste Foy, PQ G1V 4G2, CANADA
[2] UNIV LAVAL, CHUL, UNITE RECH HYPERTENS, MOL ENDOCRINOL LAB, Ste Foy, PQ G1V 4G2, CANADA
关键词
D O I
10.1210/en.137.11.4619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study sought to examine the effects of intracerebroventricular (icv) administration of corticotropin-releasing factor (CRF) on the expression of CRF, receptor messenger RNA (mRNA) within the hypothalamus as determined by quantitative in situ hybridization histochemistry. Adult male Sprague-Dawley rats were stereotaxically implanted with guide cannulae directed towards the right lateral ventricle. After 8-10 days of recovery, either 10 mu l CRF (5 mu g) or vehicle solution was injected into the lateral ventricle over a 2-min period. The rats were then deeply anesthetized at 15, 60, and 180 min after icv injection, transcardially perfused, and their brains cut into 30-mu m coronal sections. Brain sections were then processed using standard radioactive in situ hybridization histochemistry revealing the expression of the CRF, receptor mRNA. Low to moderate basal levels of CRF, receptor transcript were observed in several regions of the forebrain. However, the hybridization signal for the mRNA encoding the CRF, receptor was barely detectable in the paraventricular nucleus of the hypothalamus (PVN) of vehicle-injected rats. In contrast, 180 min after icv administration of CRF, a significant increase in CRF, receptor transcript was measured specifically in the PVN, despite having virtually any hybridization signal before 180 min. This increase in the level of receptor transcription by CRF was restricted to the type 1 receptor subtype because the hybridization signal for the CRF(2 alpha) receptor mRNA was unaffected in the brain regions in which it was located. Moreover, we confirmed previous findings of a CRF-induced neuronal activation of parvocellular neurosecretory cells of the PVN, as assessed by c-fos mRNA expression. This neuronal activation induced by exogenous CRF was also associated with a rapid and strong induction of CRF heteronuclear RNA selectively in the rat PVN, a phenomenon abolished by a pretreatment with a CRF receptor antagonist. These results provide evidence that elevated levels of central CRF may trigger CRF, receptor transcription selectively in the PVN. This positive feedback of CRF on its own receptor may represent a functional adaptation of the hypothalamic-pituitary-adrenal axis in response to stress.
引用
收藏
页码:4619 / 4629
页数:11
相关论文
共 50 条
  • [1] Alcohol increases the expression of type 1, but not type 2 alpha corticotropin-releasing factor(CRF) receptor messenger ribonucleic acid in the rat hypothalamus
    Lee, S
    Rivier, C
    MOLECULAR BRAIN RESEARCH, 1997, 52 (01): : 78 - 89
  • [2] Regulation of corticotropin-releasing factor (CRF) type-1 receptor gene expression by CRF in the hypothalamus
    Konishi, S
    Kasagi, Y
    Katsumata, H
    Minami, S
    Imaki, T
    ENDOCRINE JOURNAL, 2003, 50 (01) : 21 - 36
  • [3] Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures
    Pozzoli, G
    Bilezikjian, LM
    Perrin, MH
    Blount, AL
    Vale, WW
    ENDOCRINOLOGY, 1996, 137 (01) : 65 - 71
  • [4] Peripheral corticotropin-releasing factor (CRF) activates myenteric cholinergic and nitrinergic neurons through CRF1 receptor (CRF1) selectively in the rat colon
    Yuan, PQ
    Million, M
    Wang, LX
    Wu, SV
    Pambukhian, K
    Kimura, H
    Tache, Y
    GASTROENTEROLOGY, 2005, 128 (04) : A277 - A277
  • [5] The distribution of corticotropin-releasing factor (CRF), CRF binding sites and CRF1 receptor mRNA in the mouse cerebellum
    King, JS
    Madtes, P
    Bishop, GA
    Overbeck, TL
    CEREBELLUM: FROM STRUCTURE TO CONTROL, 1997, 114 : 55 - 66
  • [6] Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin
    Parham, KL
    Zervou, S
    Karteris, E
    Catalano, RD
    Old, RW
    Hillhouse, EW
    ENDOCRINOLOGY, 2004, 145 (08) : 3971 - 3983
  • [7] Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: Studies in primary amygdalar cultures
    Kasckow, JW
    Regmi, A
    Gill, PS
    Parkes, DG
    Geracioti, TD
    ENDOCRINOLOGY, 1997, 138 (11) : 4774 - 4782
  • [8] MPZP:: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist
    Richardson, Heather N.
    Zhao, Yu
    Fekete, Eva M.
    Funk, Cindy K.
    Wirsching, Peter
    Janda, Kim D.
    Zorrilla, Eric P.
    Koob, George F.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2008, 88 (04) : 497 - 510
  • [9] REGULATION OF THE MESSENGER RIBONUCLEIC-ACID FOR CORTICOTROPIN-RELEASING FACTOR IN THE PARAVENTRICULAR NUCLEUS AND OTHER BRAIN SITES OF THE RAT
    BEYER, HS
    MATTA, SG
    SHARP, BM
    ENDOCRINOLOGY, 1988, 123 (04) : 2117 - 2122
  • [10] Immunohistochemical visualization of corticotropin-releasing factor type 1 (CRF1) receptors in monkey brain
    Kostich, WA
    Grzanna, R
    Lu, NZ
    Largent, BL
    JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 478 (02) : 111 - 125